For people receiving urate-lowering therapy, NICE recommends aiming below 360 µmol/L (6 mg/dL), with a lower target below 300 µmol/L considered in some people with more severe gout.
For people receiving urate-lowering therapy, NICE recommends aiming below 360 µmol/L (6 mg/dL), with a lower target below 300 µmol/L considered in some people with more severe gout.
For people receiving urate-lowering therapy, NICE recommends aiming below 360 µmol/L (6 mg/dL), with a lower target below 300 µmol/L considered in some people with more severe gout.
This is general information, not an individual diagnosis or instruction to change treatment.
Evidence review: September 2026.
General educational information, not individual medical advice. Do not start, stop or change prescribed treatment based on this page.